Urantide对动脉粥样硬化大鼠脾组织中ERK1/2及P38表达的影响

doi:10.13418/j.issn.1001-165x.2022.4.10

Abstract

Abstract: Objective To observe the effect of Urantide on the expression of ERK1/2 and P38 in MAPK signaling pathway in spleen of atherosclerotic rats, and to explore the effect and mechanism of Urantide on ERK1/2 and P38 MAPK signaling pathway in spleen. Methods A total of 180 wistar rats were randomly divided into a normal group, an AS group, a Simvastatin group, a Urantide 3 days, 7 days and 14 days group. The thoracic aorta and spleen of rats were observed by HE staining. Immunofluorescence, Western blotting were used to detect the expression of ERK1/2 and P38 in the spleen of rats. Results Compared with control group, the HE staining of AS group showed typical AS pathological changes in thoracic aorta, and hyaline degeneration in the central artery of spleen, the positive expression of p-ERK1/2 and p-P38 protein in the spleen of rats significantly increased (P<0.05). Compared with AS group, the hyaline degeneration in spleen significantly reduced in Urantide groups and Simvastatin group, the positive expression of p-ERK1/2 and p-P38 protein in spleen significantly decreased, especially in the Urantide 14 days group (P<0.05). Conclusions Urantide can improve the degree of pathological changes in spleen of AS rats by inhibiting the expression of ERK1/2 and P38.

Key words: Atherosclerosis; , , Spleen; , , Urotensin Ⅱ; , , Urantide; , , MAPK; , , ERK1/2; , , P38

CLC Number:

R543.5

Xu Yuhang, Li Ying, Xie Yunpeng, Wang Tu, Cui Haipeng, Zhao Juan. Effect of Urantide on the expression of ERK1/2 and P38 in the spleen of atherosclerotic rats[J]. Chinese Journal of Clinical Anatomy, 2022, 40(4): 425-431.

References 34

[1]	Winkels H, Ehinger E, Vassallo M, et al. Atlas of the immune cell repertoire in mouse atherosclerosis defined by single-cell RNA-sequencing and mass cytometry[J]. Circ Res, 2018, 122(12): 1675-1688. DOI: 10.1161/CIRCRESAHA.117.312513.
[2]	Watanabe T, Sato K, Itoh F, et al. Emerging roles for vasoactive peptides in diagnostic and therapeutic strategies against atherosclerotic cardiovascular diseases[J]. Curr Protein Pept Sci, 2013, 14(6): 472-480. DOI: 10.2174/13892037113149990064.
[3]	Reustle A, Torzewski M. Role of p38 MAPK in atherosclerosis and aortic valve sclerosis[J]. Int J Mol Sci, 2018, 19(12): 3761. DOI: 10.3390/ijms19123761.
[4]	Mizumoto Y, Kyo S, Mori N, et al. Activation of ERK1/2 occurs independently of KRAS or BRAF status in endometrial cancer and is associated with favorable prognosis[J].Cancer Sci, 2007, 98(5): 652-658. DOI: 10.1111/j.1349-7006.2007.00445.x.
[5]	崔海鹏, 刘凯, 李颖, 等. Urantide对动脉粥样硬化大鼠肝细胞外调节蛋白激酶1/2的作用及机制[J]. 解剖学杂志, 2019, 42(3): 235-239, 282. DOI: 10.3969/j.issn.1001-1633.2019.03.004.
[6]	孙晓旭, 王途, 许倩, 等. Urantide降低动脉粥样硬化大鼠胸主动脉中p38 MAPK表达[J]. 基础医学与临床, 2019, 39(9): 1283-1288. DOI: 10.3969/j.issn.1001-6325.2019.09.013.
[7]	Pereira-Castro J, Brás-Silva C, Fontes-Sousa AP. Novel insights into the role of urotensin II in cardiovascular disease[J]. Drug Discov Today, 2019, 24(11): 2170-2180. DOI: 10.1016/j.drudis.2019.08.005.
[8]	Suguro T, Watanabe T, Ban Y, et al. Increased human urotensin II levels are correlated with carotid atherosclerosis in essential hypertension[J]. Am J Hypertens, 2007, 20(2): 211-217. DOI: 10.1016/j.amjhyper. 2006. 08.001.
[9]	Zhao J, Zhang SF, Shi Y, et al. Effects of urotensin II and its specific receptor antagonist urantide on rat vascular smooth muscle cells[J]. Bosn J Basic Med Sci,2013, 13(2): 78-83. DOI: 10.17305/bjbms. 2013.2369.
[10]	Zhao J, Miao GX, Wang T, et al. Urantide attenuates myocardial damage in atherosclerotic rats by regulating the MAPK signalling pathway[J]. Life Sci, 2020, 262(11): 118551. DOI: 10.1016/j.lfs. 2020. 118551.
[11]	张延辉, 郭晓辰, 张军平, 等. 脾调节动脉粥样硬化的相关机制研究[J]. 中国免疫学杂志，2017, 33(9): 1412-1414. DOI: 10.3969/j.issn. 1000- 484X.2017.09.029.
[12]	Wang YH， Huang ZY，Lu HX，et al. Apolipoprotein E-knockout mice show increased titers of serum anti-nuclear and anti-dsDNA antibodies[J]. Biochem Biophys Res Commun, 2012, 423(4): 805-812. DOI: 10.1016/j.bbrc.2012.06.044.
[13]	Leuschner F, Dutta P, Gorbatov R, et al. Therapeutic siRNA silencing in inflammatory monocytes in mice[J]. Nat Biotechnol, 2011, 29(11): 1005-1010. DOI: 10.1038/nbt.1989.
[14]	Grasset EK, Duhlin A, Agardh HE, et al. Sterile inflammation in the spleen during atherosclerosis provides oxidation-specific epitopes that induce a protective B-cell response[J]. Proc Natl Acad Sci U S A, 2015, 112(16): E2030-E2038. DOI: 10.1073/pnas.1421227112.
[15]	Lucas AR, Korol R, Pepine CJ. Inflammation in atherosclerosis: some thoughts about acute coronary syndromes[J]. Circulation, 2006, 113(17): e728-e732. DOI: 10.1161/CIRCULATIONAHA.105.601492.
[16]	Viola J, Soehnlein O. Atherosclerosis-a matter of unresolved inflammation[J]. Semin Immunol, 2015, 27(3): 184-193. DOI: 10.1016/j.smim.2015.03.013.
[17]	Potteaux S, Ait-Oufella H, Mallat Z. Role of splenic monocytes in atherosclerosis[J]. Curr Opin Lipidol, 2015, 26(5): 457-463. DOI: 10.1097/MOL.0000000000000223.
[18]	Chistiakov DA, Grechko AV, Myasoedova VA, et al. The role of monocytosis and neutrophilia in atherosclerosis[J]. J Cell Mol Med, 2018, 22(3): 1366-1382. DOI: 10.1111/jcmm.13462.
[19]	Robbins CS, Chudnovskiy A, Rauch PJ, et al. Extramedullary hematopoiesis generates Ly-6C(high) monocytes that infiltrate atherosclerotic lesions[J]. Circulation, 2012, 125(2): 364-374. DOI: 10.1161/CIRCULATIONAHA.111.061986.
[20]	Potteaux S, Gautier EL, Hutchison SB, et al. Suppressed monocyte recruitment drives macrophage removal from atherosclerotic plaques of Apoe-/- mice during disease regression[J]. J Clin Invest, 2011, 121(5): 2025-2036. DOI: 10.1172/JCI43802.
[21]	赵依帆, 潘思京, 高真真, 等. 动脉粥样硬化的炎症信号通路研究进展[J]. 中华老年心脑血管病杂志, 2014, 16(12): 1332-1334. DOI: 10.3969/j.issn.1009-0126.2014.12.030.
[22]	徐瑞, 黄鹏, 张祎冰, 等. p38MAPK在动脉粥样硬化机制中的研究进展[J]. 中国老年学杂志, 2019, 39(17): 4365-4368. DOI: 10.3969/j.issn.1005-9202.2019.17.079.
[23]	杨翼鹰, 陈伟燕, 孙秀亭, 等. 麝香保心丸通过抑制p38 MAPK和NF-κB信号传导通路表达对抗高糖诱导的心肌细胞损伤[J]. 中国临床解剖学杂志, 2016, 34(5): 517-522, 527. DOI: 10.13418/j.issn.1001-165x. 2016.05.009.
[24]	Sun LF, An DQ, Niyazi GL, et al. Effects of Tianxiangdan Granule treatment on atherosclerosis via NF‑κB and p38 MAPK signaling pathways[J]. Mol Med Rep, 2018, 17(1): 1642-1650. DOI: 10.3892/mmr.2017.8067.
[25]	Cheng M, Yang LG, Fan M, et al. Proatherogenic stimuli induce HuR in atherosclerosis through MAPK/ErK pathway[J]. Am J Transl Res, 2019, 11(4): 2317-2327. PMID: 31105838.
[26]	Yang Y, Kim SC, Yu T, et al. Functional roles of p38 mitogen-activated protein kinase in macrophage-mediated inflammatory responses[J]. Mediators Inflamm, 2014, 2014: 352371. DOI: 10.1155/2014/352371.
[27]	McCubrey JA, Steelman LS, Chappell WH, et al. Roles of the Raf/MEK/ERK pathway in cell growth, malignant transformation and drug resistance[J]. Biochim Biophys Acta, 2007, 1773(8): 1263-1284. DOI: 10.1016/j.bbamcr.2006.10.001.
[28]	Emtiazy M, Choopani R, Khodadoost M, et al. Atheroprotector role of the spleen based on the teaching of Avicenna (Ibn Sina)[J]. Int J Cardiol, 2013, 167(1): 26-28. DOI: 10.1016/j.ijcard.2012.06.020.
[29]	Akan AA, Sengül N, Simşek S, et al. The effects of splenectomy and splenic autotransplantation on plasma lipid levels[J]. J Invest Surg, 2008, 21(6): 369-372. DOI: 10.1080/08941930802438898.
[30]	Svistunov AA, Tarasov VV, Shakhmardanova SA, et al. Urotensin II: molecular mechanisms of biological activity[J]. Curr Protein Pept Sci, 2018, 19(9): 924-934. DOI: 10.2174/1389203718666170829162335.
[31]	Cui HP, Lin YX, Xie LD, et al. Urantide decreases hepatic steatosis in rats with experimental atherosclerosis via the MAPK/Erk/JNK pathway[J]. Mol Med Rep, 2021, 23(4): 284. DOI: 10.3892/mmr.2021.11923.
[32]	李英, 谢利德, 王途, 等. 多肽类化合物Urantide对动脉粥样硬化大鼠心脏组织中骨桥蛋白和α平滑肌肌动蛋白表达的影响[J]. 解剖学报,2021, 52(3): 446-452. DOI: 10.16098/j.issn.0529-1356. 2021. 03. 018.
[33]	Wang T, Xie LD, Bi HD, et al. Urantide alleviates the symptoms of atherosclerotic rats in vivo and in vitro models through the JAK2/STAT3 signaling pathway[J]. Eur J Pharmacol, 2021, 902: 174037. DOI: 10.1016/j.ejphar.2021.174037.
[34]	Wang T, Xie YQ, Miao GX, et al. Urotensin receptor antagonist urantide improves atherosclerosis-related kidney injury by inhibiting JAK2/STAT3 signaling pathway in rats[J]. Life Sci, 2020, 247: 11742. DOI: 10.1016/j.lfs.2020.117421.

Effect of Urantide on the expression of ERK1/2 and P38 in the spleen of atherosclerotic rats

PDF (PC)

Knowledge

Abstract

Cite this article

share this article

References 34

Related Articles 15

Metrics

Comments

Recommended 0

[1]	Jiang Jianhong, Duan Renpeng, Li Xiaofeng. Application of three-dimensional visualization technology in the anatomical variations of hilar bile ducts in Chinese population [J]. Chinese Journal of Clinical Anatomy, 2024, 42(1): 1-4.
[2]	Guo Hongzhi, Wang Yu, Zhang Jiaqi, Liang Haibin, Ma Ziwei, Feng Wei, Wu You, Si Ziyi. Evaluation of placental vascular structure in preeclampsia by vascular casting combined with CT three-dimensional model [J]. Chinese Journal of Clinical Anatomy, 2024, 42(1): 5-10.
[3]	Li Jiawei, Zhang Jing, Li Canran, Lan Wenjie, Ji Qingyu, Guo Zhiyong, Zhang Yunfeng, Liu Qi, Chen Qingwei, Li Xiaohe. X-ray measurement of proximal femur anatomical parameters in Mongolian population [J]. Chinese Journal of Clinical Anatomy, 2024, 42(1): 11-16.
[4]	. Digital measurement and clinical significance of occipitocervical Angle and posterior occipitocervical Angle in children and adolescents [J]. Chinese Journal of Clinical Anatomy, 2024, 42(1): 17-20.
[5]	Li Wen, Yang Siyi, Huang Lei, Qing Jiwen, Jiang Songtao, Zhang Lei. Morphological characteristics and clinical significance of Lisfranc ligament based on MRI [J]. Chinese Journal of Clinical Anatomy, 2024, 42(1): 21-25.
[6]	Li Fanfan, Xu Yang, Wang Xiaoxu. Therapeutic effect of shikonin on the treatment of granuloma lobular mastitis in model rats by regulating Nrf2/HO-1 signaling pathway [J]. Chinese Journal of Clinical Anatomy, 2024, 42(1): 26-32.
[7]	Wang Xinghang, Ding Jiayuan, Li Fang, Bao Cuifen, Yan Lijing. Ginsenoside Rg1 reduces the inflammatory response of microglia after oxygen glucose deprivation/resupply by inhibiting the NLRP3 inflammasome pathway [J]. Chinese Journal of Clinical Anatomy, 2024, 42(1): 33-41.
[8]	Cheng Yingying, Wu Jianjun, Cai Haiyan , Jiao Xunwen, Ma Jiangbo, Ding Yinxiu. Activation and functional changes of astrocytes cultured in vitro under inflammatory stimulation [J]. Chinese Journal of Clinical Anatomy, 2024, 42(1): 42-46.
[9]	Qi Zhi, Yang Li, Jia Qiuye, Chen Haolun, Duan Zhaoda, Wu Chunyun. Edaravone regulates Sirt3 expression in lipopolysaccharide-activated microglia via MAPKs signaling pathway [J]. Chinese Journal of Clinical Anatomy, 2024, 42(1): 47-53.
[10]	Zhang Jingjing, Wang Hongxin. Protective effect of Baicalin on rats with pulmonary hypertension through PDGF/P38 MAPK signaling pathway [J]. Chinese Journal of Clinical Anatomy, 2024, 42(1): 54-58.
[11]	Yue Qin, Chen Rongli, Xiong Jingxi, Wang Tingyi, Cai Zhiheng, Yi Qiushi, Zeng Xinyi. Effect of Bletilla striata polysaccharides on the choke-area of cross-boundary flap in rats [J]. Chinese Journal of Clinical Anatomy, 2024, 42(1): 59-64.
[12]	Li Xiaoyu , Zhang Lei , Fu Lei , Li Dongbo , Wang Guoyou. Finite element study on the treatment of Sanders type II calcaneal fracture with three-step reduction method [J]. Chinese Journal of Clinical Anatomy, 2024, 42(1): 65-70.
[13]	Wu Yanfei, Ma Jianxiong, Lu Bin, Wang Ying, Bai Haohao, Jin Hongzhen, Ma Xinlong. Study on the correlation between the reconstruction of grayscale values using CT post-processing technology and the compressive strength of the endplate [J]. Chinese Journal of Clinical Anatomy, 2024, 42(1): 71-76.
[14]	Zhuang Wanqiang, Tang Yi, Luo Yonggang, Zhang Hui. An early and mid-term retrospective study of the effects of arthroscopy combined with high tibial osteotomy on patellar position and patellofemoral joint function [J]. Chinese Journal of Clinical Anatomy, 2024, 42(1): 77-82.
[15]	Luo Ying, Dou Weiyu, Wu Xiaohang, Chen Jingkun, Peng Changgui, Pan Jianying . Risk factors of postoperative complications of calcaneal fractures treated with hippocampal plate internal fixation through minimally invasive method [J]. Chinese Journal of Clinical Anatomy, 2024, 42(1): 83-88.